Herpes simplex virus reactivation among hematopoietic stem cell transplant recipients: re-evaluating acyclovir dosage.

导出 LinkOut

翻译打印收藏纠错

作者： Nada,Alsuhebany ^[1] ; Bashayer,Alshehri ^[2] ; Atheer,Aldairem ^[1] ; Muneerah M,Aleissa ^[3] ; Hajar,AlQahtani ^[4] ; Khalid,Albarqi ^[5] ; Basil,Almotairi ^[5] ; Mohammed,AlAmri ^[5] ; Walid,Alanazi ^[5] ; Saeed,Alay ^[5] ; Bader,Alahmari ^[6] ; Mohsen,Alzahrani ^[6]

作者单位： Department of Pharmaceutical Care, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.;King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.;College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. ^[1] Department of Pharmaceutical Care, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.;King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. ^[2] Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. mmaleissa@pnu.edu.sa. ^[3] Department of Pharmaceutical Care, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.;King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.;King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. ^[4] College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. ^[5] King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.;King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.;Department of Oncology, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia. ^[6]